3/10/2024 0 Comments Torrent Pharma Derma ProductsTorrent's acquisition of Curatio is valued at 8.4x and 6.9x FY22 and FY23E EV/sales, respectively. The deal propels Torrent Pharma to top 10 players in the dermatology segment and leadership in the cosmetic dermatology space. Within dermatology, cosmetic dermatology is a leading contributor with 84% share while other 16% is from medical derma. Dermatology accounts for 95% of Curatio’s revenues. Top three and 10 brands contribute ~50% and 75% of the total sales, respectively. Torrent Pharma has acquired 100% of Curatio Healthcare for Rs 2000 crore with a strong presence in the cosmetic/paediatric dermatology segment, with a portfolio of over 50 brands (79% chronic/sub-chronic), marketed in India.Ĭuratio's revenues has grown at a CAGR of 13% over FY20-22 to Rs 224 crore and is expected to grow 23% in FY23 to Rs 275 crore.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |